Sorrento Therapeutics (NASDAQ:SRNE) Coverage Initiated at StockNews.com
Investment analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a note issued to investors on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Sorrento Therapeutics stock opened at $0.00 on Thursday. Sorrento Therapeutics has a 52 week low of […]
More Stories
System1 Group (LON:SYS1) Shares Down 0% – Should You Sell?
System1 Group PLC (LON:SYS1 – Get Free Report)’s share price fell 0% during trading on Wednesday . The company traded...
Grande West Transportation Group (CVE:BUS) Stock Price Down 2.4% – What’s Next?
Grande West Transportation Group Inc (CVE:BUS – Get Free Report) traded down 2.4% during trading on Wednesday . The stock...
Orca Gold (CVE:ORG) Stock Price Down 4.6% – Should You Sell?
Orca Gold Inc. (CVE:ORG – Get Free Report)’s share price was down 4.6% on Wednesday . The stock traded as...
Diamond Estates Wines & Spirits (CVE:DWS) Trading Down 2.4% – Here’s What Happened
Diamond Estates Wines & Spirits Inc. (CVE:DWS – Get Free Report) dropped 2.4% on Wednesday . The stock traded as...
HelloFresh (ETR:HFG) Shares Up 0.2% – Time to Buy?
HelloFresh SE (ETR:HFG – Get Free Report)’s share price traded up 0.2% during trading on Wednesday . The stock traded...
Borders & Southern Petroleum (LON:BOR) Trading 39.4% Higher – Here’s Why
Shares of Borders & Southern Petroleum plc (LON:BOR – Get Free Report) traded up 39.4% on Monday . The stock...